Autopsy report · NCT04207905

Evaluation of the Healthy Michigan Plan Section 1115 Community Engagement Requirement Waiver

“The Healthy Michigan Plan community engagement requirement was implemented on 1/1/2020. On 3/4/2020, a US District Court judge vacated the CMS approval of this policy, thereby suspending implementation of this RCT. This was not an IRB suspension.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 months before it stopped.
• 892 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University of Michigan

Sponsor type

University, hospital or other

Conditions

Health Insurance

Interventions

Healthy Michigan Plan (HMP) coverage with work requirements

Participants

892

Sites

1

Countries

United States

Trials that died the same way

• Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma
  “Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.” (61% match in meaning)
• Reducing Frailty for Older Cancer Survivors Using Supplements II
  “The study has been suspended by the IRB pending review of a study-related issue” (56% match in meaning)
• Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
  “IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.